- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - https://eyedocnews.com -

Trial to Study Treatment of Geographic Atrophy with Emixustat Hydrochloride

Posted By Dr. Ari Weitzner On May 7, 2014 @ 5:48 am In Clinical Trials,Macular Degeneration,Research,Retina | Comments Disabled

Emixustat Hydrochloride is an orally dosed compound produced by Acucela in development for the treatment of geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).

Recently published to clinicaltrials.gov were details of a multi-center, randomized, masked, multiple-dose, crossover study of the pharmacokinetics of emixustat hydrochloride in subjects with GA associated with dry AMD.

Click here [1] for details.


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: https://eyedocnews.com

URL to article: https://eyedocnews.com/007180-trial-to-study-treatment-of-geographic-atrophy-with-emixustat/

URLs in this post:

[1] Click here: http://www.clinicaltrials.gov/ct2/show/NCT02130531

Copyright © 2008 Eye Doc Talk. All rights reserved.